Annals of Oncology· @Annals_Oncology · X·· 2 天前评分70
正文 · 原文
📢 #ESMO26 concomitant paper - Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281.
🔗https://shorturl.at/c6tvw
@Daniel_J_George
1588 浏览 · 10 赞 · 4 转发 · 0 回复
会议摘要
Capivasertib (capi) + abiraterone (abi) vs placebo (pbo) + abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC): Updated overall survival (OS) from CAPItello-281
https://esmocongress.esmo.org来源：Annals of Oncology · x.com